Postmenopausal Bleeding With Early-Stage Endometrial Cancer and Major Comorbidities
62-year-old G2P2, menopause 8 years ago, reports three episodes of postmenopausal bleeding over 2 months. BMI 38, type 2 diabetes (HbA1c 8.1%), hypertension. She takes metformin and lisinopril. Transvaginal ultrasound: endometrial thickness 16 mm, heterogeneous, no fluid; ovaries normal. Office pipelle biopsy shows endometrioid adenocarcinoma, FIGO grade 1. Pelvic exam: uterus normal size, no cervical or vaginal lesions. CA-125 is 42 U/mL. Chest imaging normal. She lives alone and has a history of pulmonary embolism after knee replacement 5 years ago, for which she completed 6 months of anticoagulation. Her other medication is atorvastatin; she has no known bleeding disorder. She wants 'the least invasive cure' and is worried about surgery because her mother died after a hip fracture.
1. What preoperative staging and risk assessment are needed, and what does the grade and imaging suggest about lymph node risk?
Read the worked answer
The biopsy establishes endometrioid adenocarcinoma, grade 1, but grade alone does not stage the patient. I would assess myometrial invasion and cervical or adnexal involvement with pelvic MRI when available, and obtain cross-sectional imaging of the chest and abdomen for metastatic spread if there are symptoms or abnormal findings; CA-125 of 42 is mildly elevated and nonspecific but should not be ignored. Formal examination under anesthesia is part of staging. Grade 1 endometrioid tumors with superficial myometrial invasion generally have low lymph node risk, but depth of invasion, lymphovascular space invasion, tumor size, and molecular features refine that risk. Her obesity, diabetes, prior pulmonary embolism, and limited social support make surgical risk as important as cancer risk. Preoperative optimization should include glycemic control, VTE risk assessment, and a discussion of minimally invasive surgery, which reduces wound and thromboembolic complications compared with laparotomy.
2. Compare minimally invasive hysterectomy with bilateral salpingo-oophorectomy plus sentinel lymph node biopsy versus full lymphadenectomy, including the rationale for each.
Read the worked answer
For presumed early-stage, grade 1 endometrioid cancer, minimally invasive hysterectomy with bilateral salpingo-oophorectomy is the standard surgical approach; it provides definitive local control with less morbidity than laparotomy, particularly in an obese patient with diabetes. Bilateral salpingo-oophorectomy is appropriate after menopause because the ovaries are a source of estrogen and adnexal malignancy. Sentinel lymph node biopsy, using cervical injection of dye, allows targeted assessment of the first draining nodes with lower rates of lymphedema and nerve injury than full pelvic and para-aortic lymphadenectomy. Full lymphadenectomy is reserved for higher-risk features such as deep invasion, high grade, or suspicious nodes, because it does not improve survival in low-risk disease and adds morbidity. Sentinel mapping also improves detection of isolated nodal metastases. The choice should be discussed with the patient, and a gynecologic oncologist should perform or supervise the staging procedure.
3. She asks about fertility-sparing treatment. Is she a candidate, and what surveillance would be required if she were younger?
Read the worked answer
She is not a candidate for fertility-sparing treatment because she is postmenopausal and has completed childbearing. Fertility-sparing therapy with high-dose progestin and serial endometrial sampling is considered only in selected premenopausal women with grade 1 endometrioid cancer confined to the endometrium who strongly desire future fertility and understand the risks. Even in that setting, response rates are incomplete, recurrence is common, and hysterectomy is recommended after childbearing. For this patient, the discussion should redirect to definitive surgery and the importance of treating her obesity and diabetes, which are associated with endometrial cancer and postoperative complications. She should also be counseled that postmenopausal bleeding and a thickened endometrium made biopsy mandatory and that her cancer is likely early stage but requires surgical staging. Her fear of surgery should be addressed with specific risk-reduction measures, including VTE prophylaxis and optimization of glucose control.